{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:51:35Z","timestamp":1787017895345,"version":"build-2736575974"},"reference-count":44,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA243707"],"award-info":[{"award-number":["CA243707"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA101642"],"award-info":[{"award-number":["CA101642"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP121010"],"award-info":[{"award-number":["RP121010"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Adult-type granulosa cell tumors (AGCT) are rare ovarian tumors with few effective treatments for recurrent disease. To elucidate spatial features and cellular interactions within the AGCT tumor microenvironment, we applied imaging mass cytometry using a 34-marker panel on 130 regions from 24 AGCT samples, profiling more than 900,000 single cells. Analysis confirmed the immune \u201ccold\u201d phenotype of AGCTs and showed higher macrophage abundance in recurrent compared with primary tumors. We observed substantial heterogeneity in tissue architecture across samples, including variable presence of FOXL2+ cells embedded in collagen-rich regions (FOXL2+COL1A1+ cells). Based on tumor microenvironment composition, we defined two AGCT subtypes: AGCT-1 and AGCT-2 with distinct FOXL2+ cell distributions, differences in progesterone receptor expression, and unique transcriptomic profiles. Our findings highlight the role of macrophages, Foxl2+ subpopulations, and the extracellular matrix in AGCT progression and suggest AGCT subtype\u2013specific vulnerabilities that could inform personalized therapies for this rare malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We discovered two histologically and molecularly distinct forms of AGCTs that differ in cell composition, immune activity, and hormone signals. These findings point to new opportunities for more personalized treatment of this rare ovarian cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0333","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:39:17Z","timestamp":1759505957000},"page":"1894-1909","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment\u2013dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-8960","authenticated-orcid":false,"given":"Eleonora Y.","family":"Khlebus","sequence":"first","affiliation":[{"name":"1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-0509","authenticated-orcid":false,"given":"Veena K.","family":"Vuttaradhi","sequence":"additional","affiliation":[{"name":"1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-8963","authenticated-orcid":false,"given":"Sammy","family":"Ferri-Borgogno","sequence":"additional","affiliation":[{"name":"1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-7888","authenticated-orcid":false,"given":"Allison L.","family":"Brodsky","sequence":"additional","affiliation":[{"name":"1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-7087","authenticated-orcid":false,"given":"Barrett C.","family":"Lawson","sequence":"additional","affiliation":[{"name":"2Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-1805","authenticated-orcid":false,"given":"Samuel C.","family":"Mok","sequence":"additional","affiliation":[{"name":"1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-9925","authenticated-orcid":false,"given":"R. Tyler","family":"Hillman","sequence":"additional","affiliation":[{"name":"3Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, Rebecca and John Moores Cancer Center, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2025102703020669300_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/IGC.0b013e3182a57fb4","article-title":"The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study","volume":"23","author":"van Meurs","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"2025102703020669300_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1471-0528.13949","article-title":"Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953\u20132012: a longitudinal cohort study","volume":"124","author":"Bryk","year":"2017","journal-title":"BJOG"},{"key":"2025102703020669300_bib3","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2024.01.002","article-title":"Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors","volume":"230","author":"How","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"2025102703020669300_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0029-7844(95)00491-2","article-title":"Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin","volume":"87","author":"Gershenson","year":"1996","journal-title":"Obstet Gynecol"},{"key":"2025102703020669300_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/gyno.1998.5304","article-title":"Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study","volume":"72","author":"Homesley","year":"1999","journal-title":"Gynecol Oncol"},{"key":"2025102703020669300_bib6","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2004.12.074","article-title":"The activity of taxanes in the treatment of sex cord-stromal ovarian tumors","volume":"22","author":"Brown","year":"2004","journal-title":"J Clin Oncol"},{"key":"2025102703020669300_bib7","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/jamaoncol.2020.4574","article-title":"Effect of weekly paclitaxel with or without bevacizumab on progression-free rate among patients with relapsed ovarian sex cord-stromal tumors: the ALIENOR\/ENGOT-ov7 randomized clinical trial","volume":"6","author":"Ray-Coquard","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025102703020669300_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2014.03.573","article-title":"Hormone therapy in ovarian granulosa cell tumors: a systematic review","volume":"134","author":"Van Meurs","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2025102703020669300_bib9","doi-asserted-by":"crossref","first-page":"724.e1","DOI":"10.1016\/j.ajog.2023.02.029","article-title":"Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors","volume":"228","author":"Foster","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"2025102703020669300_bib10","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41467-018-04950-x","article-title":"KMT2D\/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary","volume":"9","author":"Hillman","year":"2018","journal-title":"Nat Commun"},{"key":"2025102703020669300_bib11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41379-018-0007-9","article-title":"TERT promoter mutation in adult granulosa cell tumor of the ovary","volume":"31","author":"Pilsworth","year":"2018","journal-title":"Mod Pathol"},{"key":"2025102703020669300_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/1541-7786.MCR-18-0359","article-title":"Mutational landscape of ovarian adult granulosa cell tumors from whole exome and targeted TERT promoter sequencing","volume":"17","author":"Alexiadis","year":"2019","journal-title":"Mol Cancer Res"},{"key":"2025102703020669300_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ygyno.2021.06.024","article-title":"Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors","volume":"162","author":"Hillman","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025102703020669300_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"2025102703020669300_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1541-7786.MCR-22-0623","article-title":"Comparative tumor microenvironment analysis of primary and recurrent ovarian granulosa cell tumors","volume":"21","author":"Khlebus","year":"2023","journal-title":"Mol Cancer Res"},{"key":"2025102703020669300_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat Methods"},{"key":"2025102703020669300_bib17","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1097\/HEP.0000000000000979","article-title":"Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse","volume":"81","author":"Yang","year":"2025","journal-title":"Hepatology"},{"key":"2025102703020669300_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"key":"2025102703020669300_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1200\/JCO.23.01115","article-title":"Spatially resolved tumor microenvironment predicts treatment outcomes in relapsed\/refractory Hodgkin lymphoma","volume":"42","author":"Aoki","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025102703020669300_bib20","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-breast-cancer-subtypes","article-title":"Subtypes of breast cancer","volume-title":"Breast cancer [Internet]","author":"Orrantia-Borunda","year":"2022"},{"key":"2025102703020669300_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/cancers14020416","article-title":"The evolution of ovarian carcinoma subclassification","volume":"14","author":"K\u00f6bel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025102703020669300_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00259-020-04771-5","article-title":"Histologic subtype classification of non-small cell lung cancer using PET\/CT images","volume":"48","author":"Han","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025102703020669300_bib23","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"van der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"key":"2025102703020669300_bib24","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41596-023-00881-0","article-title":"An end-to-end workflow for multiplexed image processing and analysis","volume":"18","author":"Windhager","year":"2023","journal-title":"Nat Protoc"},{"key":"2025102703020669300_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nmeth.4391","article-title":"histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data","volume":"14","author":"Schapiro","year":"2017","journal-title":"Nat Methods"},{"key":"2025102703020669300_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025102703020669300_bib27","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2025102703020669300_bib28","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Natl Acad Sci U S A"},{"key":"2025102703020669300_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"5 Suppl 2","key":"2025102703020669300_bib30","doi-asserted-by":"crossref","first-page":"A068","DOI":"10.1158\/1538-7445.OVARIAN23-A068","article-title":"Abstract A068: Dual multiplexing analysis of the tumor immune microenvironment of rare ovarian granulosa cell tumors identified predictors of recurrence and potential therapeutic targets","volume":"84","author":"Hilliard","year":"2024","journal-title":"Cancer Res"},{"key":"2025102703020669300_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41421-022-00492-1","article-title":"Dissecting the fate of Foxl2-expressing cells in fetal ovary using lineage tracing and single-cell transcriptomics","volume":"8","author":"Zhou","year":"2022","journal-title":"Cell Discov"},{"key":"2025102703020669300_bib32","doi-asserted-by":"crossref","first-page":"e0205494","DOI":"10.1371\/journal.pone.0205494","article-title":"Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: a histopathological study","volume":"13","author":"Fujisawa","year":"2018","journal-title":"PLoS One"},{"key":"2025102703020669300_bib33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.humpath.2013.12.015","article-title":"The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma","volume":"45","author":"Westerhoff","year":"2014","journal-title":"Hum Pathol"},{"key":"2025102703020669300_bib34","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1002\/ctm2.516","article-title":"Estrogen receptor variant ER\u03b146 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer-associated fibroblasts","volume":"11","author":"Cirillo","year":"2021","journal-title":"Clin Transl Med"},{"key":"2025102703020669300_bib35","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/febs.17270","article-title":"Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression","volume":"292","author":"Mangani","year":"2025","journal-title":"FEBS J"},{"key":"2025102703020669300_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semcancer.2019.07.006","article-title":"Estrogen receptor-mediated targeting of the extracellular matrix network in cancer","volume":"62","author":"Piperigkou","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"2025102703020669300_bib37","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.1801152","article-title":"Progesterone receptor attenuates STAT1-mediated IFN signaling in breast cancer","volume":"202","author":"Goodman","year":"2019","journal-title":"J Immunol"},{"key":"2025102703020669300_bib38","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-13-0930","article-title":"Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy","volume":"73","author":"Janzen","year":"2013","journal-title":"Cancer Res"},{"key":"2025102703020669300_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","article-title":"Aligned collagen is a prognostic signature for survival in human breast carcinoma","volume":"178","author":"Conklin","year":"2011","journal-title":"Am J Pathol"},{"key":"2025102703020669300_bib40","doi-asserted-by":"crossref","first-page":"e146987","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"key":"2025102703020669300_bib41","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1172\/JCI136760","article-title":"Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix","volume":"130","author":"Jiang","year":"2020","journal-title":"J Clin Invest"},{"key":"2025102703020669300_bib42","doi-asserted-by":"crossref","first-page":"e174528","DOI":"10.1172\/JCI174528","article-title":"Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance","volume":"134","author":"Schaer","year":"2023","journal-title":"J Clin Invest"},{"key":"2025102703020669300_bib43","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/bcr2771","article-title":"Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence in Tissues Study (BRITS)","volume":"12","author":"Thompson","year":"2010","journal-title":"Breast Cancer Res"},{"key":"2025102703020669300_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/neuonc\/noaa013","article-title":"Subtype switching in breast cancer brain metastases: a multicenter analysis","volume":"22","author":"Hulsbergen","year":"2020","journal-title":"Neuro Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0333\/3657370\/crc-25-0333.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1894\/3665498\/crc-25-0333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1894\/3665498\/crc-25-0333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:02:27Z","timestamp":1761548547000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/10\/1894\/766901\/Multiplexed-Imaging-Mass-Cytometry-Reveals-Tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0333","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30452915","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452927","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452939","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452981","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452951","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452975","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452921","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452933","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452945","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452957","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452948","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452918","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452960","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452972","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452984","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452930","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452942","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452966","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452978","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452912","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452924","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30452936","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8111978","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}